SCHEMBL13858929

SCHEMBL13858929

O[C@@H]1CC/C=C\CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11913654 1.00
SCHEMBL560703 1.00
SCHEMBL21724830 1.00
SCHEMBL868155 1.00
SCHEMBL15299654 1.00
SCHEMBL27285218 1.00
SCHEMBL560702 1.00
SCHEMBL10931150 0.97 TSHR (0.47)
SCHEMBL15130019 0.97 TSHR (0.47)
SCHEMBL9352358 0.97 TSHR (0.47)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025242715-A1 METHOD FOR RAPIDLY PROVIDING PYRIDAZINES FROM TETRAZINES AND CIS-DIENOPHILES TETRAKIT TECHNOLOGIES APS (DK) 2025-11-27 WO disclosed
EP-4653425-A1 METHOD FOR RAPIDLY PROVIDING PYRIDAZINES FROM TETRAZINES AND CIS-DIENOPHILES Tetrakit Technologies ApS (DK) 2025-11-26 EP disclosed
WO-2025051721-A1 METHOD FOR RAPID OXIDATION OF DIHYDROPYRIDAZINES TO PYRIDAZINES UNIVERSITY OF COPENHAGEN (DK) 2025-03-13 WO disclosed
EP-4520751-A1 METHOD FOR RAPID OXIDATION OF DIHYDROPYRIDAZINES TO PYRIDAZINES University of Copenhagen (DK) 2025-03-12 EP disclosed
US-20240207434-A1 METHODS FOR PREPARING CYCLOOCTENES ANDCONJUGATES THEREOF TAGWORKS PHARMACEUTICALS B.V. (NL) 2024-06-27 US disclosed
WO-2023170164-A1 METHOD FOR PROVIDING A LABELED SINGLE ISOMERIC CHEMICAL ENTITY TARGETING VECTOR BASED ON THE USE OF A SYMMETRICAL DIENE UNIVERSITY OF COPENHAGEN (DK) 2023-09-14 WO disclosed
EP-2709666-A1 BIO-ORTHOGONAL DRUG ACTIVATION Koninklijke Philips N.V. (NL) 2014-03-26 EP disclosed
WO-2012156918-A1 BIO-ORTHOGONAL DRUG ACTIVATION KONINKLIJKE PHILIPS ELECTRONICS N.V. (NL) 2012-11-22 WO disclosed